Page last updated: 2024-09-05

gr 144053 and dx 9065a

gr 144053 has been researched along with dx 9065a in 1 studies

Compound Research Comparison

Studies
(gr 144053)
Trials
(gr 144053)
Recent Studies (post-2010)
(gr 144053)
Studies
(dx 9065a)
Trials
(dx 9065a)
Recent Studies (post-2010) (dx 9065a)
21129278

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collen, D; Kozawa, O; Matsuno, H; Matsuo, O; Nishida, M; Uematsu, T; Ueshima, S1

Other Studies

1 other study(ies) available for gr 144053 and dx 9065a

ArticleYear
tPA, but not uPA, significantly affects antithrombotic therapy by a glycoprotein IIb/IIIa antagonist, but not by a factor Xa inhibitor.
    Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:6

    Topics: Animals; Bleeding Time; Factor Xa Inhibitors; Fibrinolytic Agents; Indicators and Reagents; Mice; Naphthalenes; Partial Thromboplastin Time; Piperazines; Piperidines; Plasminogen Activators; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Propionates; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator

2000